Showing 281 - 300 results of 103,443 for search '(( 5 ((026 decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 2 de decrease ))', query time: 1.37s Refine Results
  1. 281
  2. 282
  3. 283
  4. 284
  5. 285
  6. 286

    Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

    Published 2019
    “…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”
  7. 287

    Decreased Sho levels correlate with the amount of PrP<sup>Sc</sup> C2 fragment present in prion-infected animals. by Joel C. Watts (195735)

    Published 2011
    “…<p>(<b>A</b>) Quantification of Sho levels in meadow voles before and after infection with RML, Sc237, and 301V prions. …”
  8. 288
  9. 289
  10. 290
  11. 291
  12. 292
  13. 293
  14. 294

    Significant decrease of SMAD4 protein in DBA iPSCs. by Jingping Ge (636557)

    Published 2015
    “…A) Slight decrease of mRNA level of <i>SMAD4</i> in the DBA iPSCs with <i>RPS19</i> or <i>RPL5</i> mutations. …”
  15. 295
  16. 296

    sC5b-9 patients decrease in patients treated with mycophenolate mofetil. by Joshua M. Thurman (517193)

    Published 2015
    “…When analyzed separately based upon treatment, the decrease in sC5b-9 levels was due to a decrease in patients treated with mycophenolate mofetil (P < 0.001 by linear regression; n = 12 for all time-points). …”
  17. 297
  18. 298

    Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX by Jeremy M. DeSilva (7247009)

    Published 2021
    “…<p>Human brain size nearly quadrupled in the six million years since Homo last shared a common ancestor with chimpanzees, but human brains are thought to have decreased in volume since the end of the last Ice Age. …”
  19. 299

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    “…Cost-based pricing models are discussed as a possibility for cost containment. This study focuses on two drugs, pembrolizumab (Keytruda) and daratumumab (Darzalex), to explore the potential effect of indication broadening on the estimated price when using the cost-based pricing (CBP) model proposed by Uyl-de Groot and Löwenberg (2018).…”
  20. 300